Merck plans big vaccine expansion in India
Merck is beefing up its sales and marketing forces in India as it aims at evolving into the country's biggest vaccine supplier by 2013. According to a report by FinancialWire, Merck says it will hire some 1,500 people in India as it expands on the two vaccines it already markets on the subcontinent. The pharma giant is following in the footsteps of GlaxoSmithKline and Sanofi-Aventis, which have already established ambitious vaccine groups in India.
Slightly more than a third of the country's 1 billion citizens are under the age of 14, offering a huge market for pediatric vaccines. One in six Indians are under the age of six. And the government has been conducting mass education campaigns aimed at educating its huge population about the need for vaccines.
India, meanwhile, has already established a reputation as a low-cost center for vaccine manufacturing and research. According to a report from the research firm RNCOS, roughly two thirds of the low-cost vaccines made in India are exported to other countries.
- read the report from Trading Markets
Related Articles:
Merck's India sub aims for big growth
Merck's McGlynn has key role developing vaccines
Indian developer inks R&D pact with Merck
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A; Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
More Research Reports >>
